Cite
MLA Citation
Diana Bradford et al.. “FDA Accelerated Approval of Pembrolizumab for Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma.” Oncologist, vol. 25, 2020, pp. e1077–e1082. http://access.bl.uk/ark:/81055/vdc_100158312698.0x00001c